In preclinical ALS studies, rapamycin reduced TDP-43 fragments accumulation and restored TDP-43 nuclear localization in cell lines12 and in human stem cell-derived neurons and astrocytes with mutant TDP43, where rapamycin enhanced survival9. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.